Why Did Unicure Soar on Huntington’s Data?

Michelle Ross breaks down Unicure’s gene therapy results and why the stock remains attractive after the dramatic move.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!